Stock Updates

Is this Large Market Cap Stock target price reasonable for Bristol-Myers Squibb Company (NYSE:BMY) ?

The company in question is, Bristol-Myers Squibb Company (NYSE:BMY) currently with a stock price of 53.2 (0.51% today). The market cap for Bristol-Myers Squibb Company is 87647, and is in the sector Healthcare, and Drug Manufacturers – Major industry. The target price for Bristol-Myers Squibb Company is 55.38. Currently Bristol-Myers Squibb Company is trading with a P/E of 20.02, and a forward P/E of 17.4. Average volume for Bristol-Myers Squibb Company is 13186.22 and so far today it is 8098700.

Performance in the last year for Bristol-Myers Squibb Company has been -20.76%. For EPS growth, Bristol-Myers Squibb Company has seen a growth of 184.60%, and is looking to grow in the next year to 9.10%. More long term stats show that EPS growth has been 4.20% over the last five years and could be 11.79% for the next five years. Bristol-Myers Squibb Company has seen sales growth quarter over quarter at 22.30%, with EPS growth quarter over quarter at 550.30%. The 20-day simple moving average is -1.79%, with the 200-day simple moving average coming to -6.54%.

Since the IPO date for Bristol-Myers Squibb Company on the 06/01/1972, Bristol-Myers Squibb Company has seen performance year to date to be -7.70%. With Bristol-Myers Squibb Company trading at 53.2, the dividend yield is 2.93%, and the EPS is 2.66.

So could Bristol-Myers Squibb Company, be undervalued? Well as said before P/E is 20.02. The PEG is 1.7, P/S is 4.51 and the P/B is at 5.51. The P/cash is 13.8, with P/free cash flow at *TBA.

Bristol-Myers Squibb Company ability to deal with debt shows that the current ratio is 1.6, and the quick ratio is 1.4. This is with long term debt/equity at 0.35, and total debt/equity at 0.41.

In terms of margins, Bristol-Myers Squibb Company has a gross margin of 74.60%, an operating margin of 30.80% and a profit margin of 22.90%.Payout ratio for Bristol-Myers Squibb Company is 57.00%. Return on assets come to 13.50% with return on investment coming to 20.00%.

Insider ownership for Bristol-Myers Squibb Company, is at 0.20% and institutional ownership comes to 72.60%. Outstanding shares are at 1647.5. While shares float is 1644.94. The float short is currently 1.43%, and short ratio is 1.79.

Graphs: Bristol-Myers Squibb Company NYSE: BMY | Thursday April 20, 2017

BMY

Bristol-Myers Squibb Company NYSE: BMY

Candle

Advanced

BMY

Bristol-Myers Squibb Company NYSE: BMY

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment